. Author manuscript; available in PMC: 2018 Jul 1.

Published in final edited form as: Cephalalgia. 2017 Apr 6;37(8):795–800. doi: 10.1177/0333102416668654

Table 2.

Difference between baseline and follow-up T2-values (ms) in migraineurs and controls

	Putamen		Putamen Posterior		Nucleus Caudatus		Globus Pallidus		Substantia Nigra (pars reticularis)		Substantia Nigra (pars compacta)		Nucleus Ruber
	CO	MIG	CO	MIG	CO	MIG	CO	MIG	CO	MIG	CO	MIG	CO	MIG
T2-value Baseline Follow-up	75.3	74.3	73.5	71.8	83.2	82.5	74.1	72.9	77.0	75.5	81.8	81.6	84.0	79.7
T2-value Baseline Follow-up	78.2	77.5	75.7	75.4	86.4	85.8	73.6	73.8	73.0	73.4	85.3	84.8	81.8	82.0
[95% CI];p-valueBaseline vs. follow-up (adjusted for age)	[2.0–3.8]	[2.3–4.1]	[1.1–3.4]	[2.3–4.8]	[2.1–4.3]	[2.4–4.1]	[−2.1–2.0]	[−0.3–2.0]	[−8.0–0.0]	[−4.6–0.3]	[1.8–5.3]	[2.0–4.4]	[−6.7–2.4]	[0.0–4.6]
[95% CI];p-valueBaseline vs. follow-up (adjusted for age)	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	0.6	0.1	0.05	0.08	< 0.001	< 0.001	0.3	0.05

CO=controls; MIG=migraineurs